Privia Health Group, Inc. income statement PRVA

In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, Privia Health Group, Inc. reported revenue of $657.0 million, up 13.2% from the same quarter a year earlier. Net income was $13.5 million, a profit margin of 2.1%. Operating income came to $20.5 million, an operating margin of 3.1%. Diluted earnings per share were $0.10.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the same quarter a year earlier.

Line
TTM
Sep 30, 2026
Q3 FY2026
Sep 30, 2026
Q2 FY2026
Jun 30, 2026
Q1 FY2026
Mar 31, 2026
Q4 FY2025
Dec 31, 2025
Q3 FY2025
Sep 30, 2025
Q2 FY2025
Jun 30, 2025
Q1 FY2025
Mar 31, 2025
Q4 FY2024
Dec 31, 2024
Revenue
2,435
+19.2%
657
+13.2%
633
+21.4%
604
+25.8%
541
+17.4%
580
+32.5%
521
+23.4%
480
+15.6%
461
+4.6%
Selling, general and administrative
177
+4.1%
44
-4.7%
48
+7.5%
50
+28.4%
36
-12.6%
47
+23.5%
44
+23.9%
39
+1.1%
41
+14.1%
Operating income
51
+80.9%
21
+42.6%
12
+252.9%
7
+42.2%
11
+114.9%
14
+147.8%
3
-34.6%
5
+534.0%
5
+269.6%
Pretax income
62
+59.9%
22
+33.5%
17
+191.6%
9
+14.2%
13
+66.7%
17
+109.0%
6
-28.8%
8
+114.1%
8
+88.0%
Income tax
23
+63.9%
8
+11.7%
7
+185.7%
6
+166.3%
3
+4.9%
7
+71.7%
2
-28.2%
2
+180.0%
3
+36.6%
Net income
35
+91.3%
13
+96.6%
9
+236.7%
3
-27.4%
9
+108.0%
7
+94.1%
3
-22.5%
4
+41.4%
4
+55.0%
Basic EPS
0.28
+85.4%
0.11
+83.3%
0.07
+250.0%
0.02
-33.3%
0.07
+102.9%
0.06
+100.0%
0.02
-33.3%
0.03
+0.0%
0.04
+52.4%
Diluted EPS
0.26
+85.9%
0.10
+100.0%
0.07
+250.0%
0.02
-33.3%
0.07
+101.2%
0.05
+66.7%
0.02
-33.3%
0.03
+50.0%
0.03
+53.4%
Weighted average shares, basic
125
+3.2%
128
+3.9%
126
+3.3%
124
+2.9%
123
+2.5%
123
+2.6%
122
+2.4%
121
+1.8%
120
+1.7%
Weighted average shares, diluted
131
+2.9%
133
+3.1%
132
+2.6%
131
+2.4%
130
+3.4%
129
+2.4%
128
+2.5%
128
+2.2%
126
+1.0%
Other measures
Depreciation and amortization
13
+40.9%
4
+26.6%
3
+29.9%
3
+72.6%
3
+45.0%
3
+53.9%
3
+42.1%
2
+4.4%
2
+3.4%
EBITDA
64
+71.1%
24
+40.0%
15
+155.6%
11
+50.3%
14
+96.8%
17
+125.6%
6
-14.4%
7
+169.3%
7
+121.8%
Margins
Operating margin
2.10%
3.13%
1.86%
1.23%
2.08%
2.48%
0.64%
1.09%
1.14%
Pretax margin
2.53%
3.39%
2.65%
1.54%
2.47%
2.87%
1.10%
1.70%
1.74%
Profit margin
1.43%
2.05%
1.43%
0.51%
1.69%
1.18%
0.52%
0.88%
0.95%
EBITDA margin
2.62%
3.66%
2.39%
1.77%
2.57%
2.96%
1.14%
1.48%
1.54%
Effective tax rate
37.40%
34.45%
41.89%
60.15%
20.84%
41.18%
42.76%
25.81%
33.10%
How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

Company profile

Industry
Services-Health Services (SIC 8000)
Listed as
PRVA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Arlington, VA
SEC filer status
Large accelerated filer
SEC CIK
1759655
Former names
PH Group Parent Corp. (until Mar 11, 2020)

Other Services-Health Services companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.